#ESMO22 Highlights on nirogacestat in patients with progressing desmoid tumours: The DeFi study

1 Views
administrator
administrator
07/04/23

LBA2 - DeFi: A Phase 3, Randomized Controlled Trial of Nirogacestat Versus Placebo for Progressing Desmoid Tumors (DT)
Presented by Bernd Kasper, DE

Produced by the European Society for Medical Oncology
http://oncologypro.esmo.org

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next